MDK and neurofibromatosis type 1: In light of previous work demonstrating elevated midkine (MDK) levels in NF1 patient samples, including low-grade peripheral nerve sheath tumors (neurofibromas14) and skin15, we employed a commercial array containing MDK and other cytokines.